open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:
Get Citation

8. Evaluation of a new system for in-vivo dosimetry based on MOSFET detectors

P.F. Kukołowicz, K. Buliński, K. Lis, J. Miedzińska
DOI: 10.1016/S1507-1367(01)70378-1
·
Rep Pract Oncol Radiother 2001;6(1):30.

open access

Vol 6, No 1 (2001)
Untitled
Published online: 2001-01-01
Submitted:

Abstract

Purpose

: In Holycross Cancer Centre in Kielce in vivo dosimetry is performed with new miniature detectors called MOSFET. MOSFETs are advertised by Thomson & Nielsen company as almost ideal detector for in-vivo dosimetry: they are isotropic, can be treated as point detector fully transparent to treatment beam, having zero temperature and negligible energy effect, can be used either for electron and photon radiation, in teletherapy and brachytherapy, can be used in several QA procedures, very easy and convenient for handling and very low time consuming. Our experience both from extensive tests and clinical use will be presented.

Results

: From our experience MOSFETs detectors can be treated as isotropic, are fully transparent for radiation, can be used both in teletherapy and brachyterapy. For application in brachyterapy special catheters with lead localisation markers must be used. The energy dependence cannot be considered as negligible. For 6 and 15 MV X photons calibration factors differ of about 5%. Reproducibility depends strongly on the dose. It decreases very much for very small doses (for dose 60 cGy – 1 standard deviation is of 2,5%). Very useful advantage of MOSFET detectors is their applicability for surface dose measurements. More details will be presented during the congress.

Conclusion

: MOSFET detectors can be effectively used for in-vivo dosimetry in tele and brachytherapy. The reproducibility should be improved.

Abstract

Purpose

: In Holycross Cancer Centre in Kielce in vivo dosimetry is performed with new miniature detectors called MOSFET. MOSFETs are advertised by Thomson & Nielsen company as almost ideal detector for in-vivo dosimetry: they are isotropic, can be treated as point detector fully transparent to treatment beam, having zero temperature and negligible energy effect, can be used either for electron and photon radiation, in teletherapy and brachytherapy, can be used in several QA procedures, very easy and convenient for handling and very low time consuming. Our experience both from extensive tests and clinical use will be presented.

Results

: From our experience MOSFETs detectors can be treated as isotropic, are fully transparent for radiation, can be used both in teletherapy and brachyterapy. For application in brachyterapy special catheters with lead localisation markers must be used. The energy dependence cannot be considered as negligible. For 6 and 15 MV X photons calibration factors differ of about 5%. Reproducibility depends strongly on the dose. It decreases very much for very small doses (for dose 60 cGy – 1 standard deviation is of 2,5%). Very useful advantage of MOSFET detectors is their applicability for surface dose measurements. More details will be presented during the congress.

Conclusion

: MOSFET detectors can be effectively used for in-vivo dosimetry in tele and brachytherapy. The reproducibility should be improved.

Get Citation
About this article
Title

8. Evaluation of a new system for in-vivo dosimetry based on MOSFET detectors

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 6, No 1 (2001)

Pages

30

Published online

2001-01-01

DOI

10.1016/S1507-1367(01)70378-1

Bibliographic record

Rep Pract Oncol Radiother 2001;6(1):30.

Authors

P.F. Kukołowicz
K. Buliński
K. Lis
J. Miedzińska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl